DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

NGL Fine-Chem Limited — Investor Presentation

NSE 14 min ago·17 Aug 2026, 9:32 am

NGL Fine-Chem

NGL Fine-Chem Limited has released its latest investor presentation to the stock exchanges. This document typically outlines the company's strategic roadmap, financial performance, and future growth plans for the upcoming period.

For investors, this update is a key opportunity to understand management's vision and assess the company's trajectory. It provides transparency into operational targets and helps validate the stock's valuation against its stated goals.

Investors should focus on the guidance provided regarding revenue growth, margin expansion, and new product launches. Monitoring the company's ability to execute its strategy will be crucial in the coming quarters.